1. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150–154
2. Malone JI, Lowitt S, Corsico N, Orfalian Z (1992) Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine. Int J Clin Pharm Res 12: 237–241
3. Merry AC, Kamijo M, Lattimer SA, Ristic H, Sima AAF (1994) Long term prevention and intervention effects of acetyl-L-carnitine on diabetic neuropathy. Diabetes 43 [Suppl 1]: 108A (Abstract)
4. Stevens M, Lattimer SA, Feldman E (1994) Protective effects of Acetyl-L-carnitine on ketogenesis and sciatic nerve function in the streptozotocin diabetic rat. Diabetes 43 [Suppl 1]: 17A (Abstract)
5. Sass RL, Wermess P (1973) Acetylcarnitine: on the relationship between structure and function. Biochem Biophys Res Commun 55: 736–742